BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 22151356)

  • 21. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
    Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
    J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease.
    Ljungvall I; Höglund K; Carnabuci C; Tidholm A; Häggström J
    J Vet Intern Med; 2011; 25(5):1036-43. PubMed ID: 21848946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels.
    Mead SE; Beijerink NJ; O'Brien M; Wade CM
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
    Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
    J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for coughing in dogs with naturally acquired myxomatous mitral valve disease.
    Ferasin L; Crews L; Biller DS; Lamb KE; Borgarelli M
    J Vet Intern Med; 2013; 27(2):286-92. PubMed ID: 23398050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.
    Boswood A; Gordon SG; Häggström J; Vanselow M; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Schummer C; Watson P
    J Vet Intern Med; 2020 May; 34(3):1108-1118. PubMed ID: 32200574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Holter monitoring in 36 dogs with myxomatous mitral valve disease.
    Crosara S; Borgarelli M; Perego M; Häggström J; La Rosa G; Tarducci A; Santilli RA
    Aust Vet J; 2010 Oct; 88(10):386-92. PubMed ID: 20854294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
    Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
    Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent mitral regurgitation in Cavalier King Charles spaniels: Short-term progression and influence of stress tests.
    Reimann MJ; Møller JE; Häggström J; Åkerström LLB; Martinussen T; Olsen LH
    Vet J; 2020 Apr; 258():105457. PubMed ID: 32564867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
    Reimann MJ; Ljungvall I; Hillström A; Møller JE; Hagman R; Falk T; Höglund K; Häggström J; Olsen LH
    Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of canine myxomatous mitral valve disease.
    O'Brien MJ; Beijerink NJ; Wade CM
    Anim Genet; 2021 Aug; 52(4):409-421. PubMed ID: 34028063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA; Singh MK; Kass PH; Griffiths LG
    J Vet Cardiol; 2015 Jun; 17(2):120-8. PubMed ID: 26007710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.
    Markby GR; Macrae VE; Corcoran BM; Summers KM
    BMC Vet Res; 2020 Sep; 16(1):350. PubMed ID: 32967675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of left ventricular pressure change by Doppler echocardiography in dogs with chronic mitral valve disease at different stages of congestive heart failure.
    Kim YH; Choi GJ; Park C
    Vet Radiol Ultrasound; 2018 Nov; 59(6):758-766. PubMed ID: 30184293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
    Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
    J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019-2021): 98 cases.
    Matson H; Llewellyn EA
    J Vet Emerg Crit Care (San Antonio); 2024; 34(3):231-237. PubMed ID: 38809224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue Doppler and strain imaging in dogs with myxomatous mitral valve disease in different stages of congestive heart failure.
    Tidholm A; Ljungvall I; Höglund K; Westling AB; Häggström J
    J Vet Intern Med; 2009; 23(6):1197-207. PubMed ID: 19909428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
    Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
    J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Reimann MJ; Fredholm M; Cremer SE; Christiansen LB; Meurs KM; Møller JE; Häggström J; Lykkesfeldt J; Olsen LH
    J Vet Intern Med; 2021 Nov; 35(6):2596-2606. PubMed ID: 34599615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension.
    Poser H; Berlanda M; Monacolli M; Contiero B; Coltro A; Guglielmini C
    J Vet Cardiol; 2017 Jun; 19(3):228-239. PubMed ID: 28579307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.